Pharmacological retention of oral mucosa progenitor/stem cells

Journal of Dental Research

Volumn 88, Issue 12, 2009, Pages 1113-1118

  Izumi, K ^a,c   Inoki, K ^a,b   Fujimori, Y ^b   Marcelo, C L ^b   Feinberg, S E ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

MTOR; Oral keratinocyte; Progenitor; Rapamycin; Stem cell

Indexed keywords

ANTIINFECTIVE AGENT; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE; RAPAMYCIN; S6 KINASE;

ARTICLE; CELL ADHESION; CELL CLONE; CELL CULTURE; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SIZE; COMPARATIVE STUDY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; EPITHELIUM CELL; FLOW CYTOMETRY; HUMAN; KERATINOCYTE; MOUTH MUCOSA; PHYSIOLOGY; REGENERATION; STEM CELL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTI-BACTERIAL AGENTS; CELL ADHESION; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SIZE; CELLS, CULTURED; CLONE CELLS; EPITHELIAL CELLS; FLOW CYTOMETRY; HUMANS; KERATINOCYTES; MOUTH MUCOSA; PROTEIN KINASES; REGENERATION; RIBOSOMAL PROTEIN S6 KINASES; SIROLIMUS; STEM CELLS;

EID: 70450152080     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034509350559     Document Type: Article

References (31)

1. Aissat N., Le Tourneau C., Ghoul A., Serova M., Bieche I., Lokiec F., et al. (2008). Antiproliferative effects of rapamycin as a single agent and in combination with carboplatin and paclitaxel in head and neck cancer cell lines. Cancer Chemother Pharmacol 62: 305-313.
2. Amornphimoltham P., Patel V., Leelahavanichkul K., Abraham RT, Gutkind JS (2008). A retroinhibition approach reveals a tumor cell-autonomous response to rapamycin in head and neck cancer. Cancer Res 68: 1144-1153.
3. Barrandon Y., Green H. (1987). Three clonal types of keratinocyte with different capacities for multiplication. Proc Natl Acad Sci USA 84: 2302-2306.
4. Bianco P., Robey PG (2001). Stem cells in tissue engineering. Nature 414: 118-121.
5. Calautti E., Li J., Saoncella S., Brissette JL, Goetinck PF (2005). Phosphoinositide 3-kinase signaling to Akt promotes keratinocyte differentiation versus death. J Biol Chem 280: 32856-32865.
6. Croagh D., Phillips WA, Redvers R., Thomas RJ, Kaur P. (2007). Identification of candidate murine esophageal stem cells using a combination of cell kinetic studies and cell surface markers. Stem Cells 25: 313-318.
7. Dolznig H., Grebien F., Sauer T., Beug H., MÜllner EW (2004). Evidence for a size-sensing mechanism in animal cells. Nat Cell Biol 6: 899-905.
8. Fingar DC, Salama S., Tsou C., Harlow E., Blenis J. (2002). Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev 16: 1472-1487.
9. Fumarola C., La Monica S., Alfieri RR, Borra E., Guidotti GG (2005). Cell size reduction induced by inhibition of the mTOR/S6K-signaling pathway protects Jurkat cells from apoptosis. Cell Death Differ 12: 1344-1357.
10. Garlick JA, Fenjves ES (1996). Keratinocyte gene transfer and gene therapy. Crit Rev Oral Biol Med 7: 204-221.
11. Hayashi R., Yamato M., Saito T., Oshima T., Okano T., Tano Y., et al. (2008). Enrichment of corneal epithelial stem/progenitor cells using cell surface markers, integrin alpha6 and CD71. Biochem Biophys Res Commun 367: 256-263.
12. Inoki K., Ouyang H., Li Y., Guan KL (2005). Signaling by target of rapamycin proteins in cell growth control. Microbiol Mol Biol Rev 69: 79-100.
13. Izumi K., Feinberg SE, Iida A., Yoshizawa M. (2003). Intraoral grafting of an ex vivo produced oral mucosa equivalent: a preliminary report. Int J Oral Maxillofac Surg 32: 188-197.
14. Izumi K., Tobita T., Feinberg SE (2007). Isolation of human oral keratinocyte progenitor/stem cells. J Dent Res 86: 341-346.
15. Kaur P. (2006). Interfollicular epidermal stem cells: identification, challenges, potential. J Invest Dermatol 126: 1450-1458.
16. Kim JE, Chen J. (2004). Regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis. Diabetes 53: 2748-2756.
17. Kim RH, Kang MK, Shin KH, Oo ZM, Han T., Baluda MA, et al. (2007). Bmi-1 cooperates with human papillomavirus type 16 E6 to immortalize normal human oral keratinocytes. Exp Cell Res 313: 462-472.
18. Kirschner M., Montazem A., Hilaire HS, Radu A. (2006). Long-term culture of human gingival keratinocyte progenitor cells by down-regulation of 14-3-3 sigma. Stem Cells Dev 15: 556-565.
19. Lamouille S., Derynck R. (2007). Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J Cell Biol 178: 437-451.
20. Lavker RM, Sun TT (2000). Epidermal stem cells: properties, markers, and location. Proc Natl Acad Sci USA 97: 13473-13475.
21. Le Tourneau C., Faivre S., Siu LL (2007). Molecular targeted therapy of head and neck cancer: review and clinical development challenges. Eur J Cancer 43: 2457-2466.
22. Lee CH, Inoki K., Guan KL (2007). mTOR pathway as a target in tissue hypertrophy. Annu Rev Pharmacol Toxicol 47: 443-467.
23. Mooney DJ, Vandenburgh H. (2008). Cell delivery mechanisms for tissue repair. Cell Stem Cell 2: 205-213.
24. Morrison SJ, Spradling AC (2008). Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell 132: 598-611.
25. Nakashima K., Colamarino S., Gage FH (2004). Embryonic stem cells: staying plastic on plastic. Nat Med 10: 23-24.
26. Parenteau NL, Rosenberg L., Hardin-Young J. (2004). The engineering of tissues using progenitor cells. Curr Top Dev Biol 64: 101-139.
27. Potten CS, Booth C. (2002). Keratinocyte stem cells: a commentary. J Invest Dermatol 119: 888-899.
28. Raslova H., Baccini V., Loussaief L., Comba B., Larghero J., Debili N., et al. (2006). Mammalian target of rapamycin (mTOR) regulates both proliferation of megakaryocyte progenitors and late stages of megakaryocyte differentiation. Blood 107: 2303-2310.
29. Westergaard M., Henningsen J., Johansen C., Rasmussen S., Svendsen ML, Jensen UB, et al. (2003). Expression and localization of peroxisome proliferator-activated receptors and nuclear factor kappaB in normal and lesional psoriatic skin. J Invest Dermatol 121: 1104-1117.
30. Wullschleger S., Loewith R., Hall MN (2006). TOR signaling in growth and metabolism. Cell 124: 471-484.
31. Youn SW, Kim DS, Cho HJ, Jeon SE, Bae IH, Yoon HJ, et al. (2004). Cellular senescence induced loss of stem cell proportion in the skin in vitro. J Dermatol Sci 35: 113-123.